Biogen Inc.
BIIB
•Stock Analysis$126.08
+0.00 (+0.00%)• Live
Biogen Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Biogen Inc.
Key Financial Metrics
for Biogen Inc.
P/E Ratio
13.14
Revenue Growth
-1.62%
EPS Growth
+39.65%
Market Cap
$19.50B
Dividend Yield
0.00%
Debt/Equity
0.39
ROIC
+7.84%
FCF Yield
+11.77%
View additional metrics
Valuation
P/B Ratio1.14
EV/Sales2.40
Financial Health
Current Ratio1.44
Return on Assets+12.36%
Analyst Recommendations
for Biogen Inc.
47 analysts
Consensus: Buy
About
for Biogen Inc.
Company Details
for Biogen Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Christopher A. Viehbacher
Employees
7,605
Market Cap
18.47B
Exchange
NASDAQ Global Select
IPO Date
September 17, 1991
Website
www.biogen.comCIK
0000875045
ISIN
US09062X1037
CUSIP
09062X103
Country
US
Balance Sheet
for Biogen Inc.
Cash Flow Statement
for Biogen Inc.
Income Statement
for Biogen Inc.
News
No news available at the moment.